Press Releases

 
Press Releases
Date Title and Summary View
May 28, 2015 NOVATO, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that Julie Anne Smith, President and Chief Executive Officer, will present at the following investor conferences: Jefferies 2015 Global Healthcare Conference on Thursday, June 4, 2015 at 9:30 a.m. EDT (6:30 a.m. PDT) in New York...
May 7, 2015 Reports PROCYSBI® Sales of $20.5 Million in First Quarter Company to Host Conference Call and Webcast Today at 4:30 p.m. ET/1:30 p.m. PT NOVATO, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) reported financial results for the first quarter ended March 31, 2015 and provided an update on recent corporate d...
May 6, 2015 NOVATO, Calif., May 6, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it will present at the following conference: Julie Anne Smith, President and Chief Executive Officer, will present at the Bank of America Merrill Lynch 2015 Healthcare Conference on Wednesday, May 13, 2015, at 1:00 p.m. PDT (...
Apr 30, 2015 NOVATO, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release first quarter 2015 financial results on Thursday, May 7, 2015 after market close. Management will conduct a conference call and live audio webcast at 4:30 p.m. EDT (1:30 p.m. PDT) that day to discuss the financi...
Apr 23, 2015 NOVATO, Calif., April 23, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) will host an Investor Day on Thursday, April 30, 2015, from 8:30 a.m. to 12:00 p.m. EDT (5:30 a.m. to 9:00 a.m. PDT) in New York City. Julie Anne Smith, President and Chief Executive Officer, and other members of the Raptor management team will provide a co...
Apr 8, 2015 NOVATO, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq: RPTP) today announced that Krishna Polu, M.D., Chief Medical Officer, will be a speaker at the following conference: Inaugural Neurology Innovation Conference on Sunday, April 19, 2015, at 2:05pm ET in Washington, D.C. Dr. Polu plans to discuss the ...
Apr 8, 2015 NOVATO, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people affected by rare and debilitating diseases, today announced the closing of its underwritten public offering of 10,925,000 shares of its common stock a...
Apr 2, 2015 NOVATO, Calif., April 2, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people affected by rare and debilitating diseases, today announced that it has priced an underwritten public offering of 9,500,000 shares of its common stock...
Mar 30, 2015 NOVATO, Calif., March 30, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP), a biopharmaceutical company focused on developing and commercializing transformative treatments for people affected by rare and debilitating diseases, today announced that it has commenced an underwritten public offering of $75 million of shares of its com...
Mar 11, 2015 NOVATO, Calif., March 11, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on March 9, 2015, the Compensation Committee of the Company's Board of Directors approved grants of inducement stock options to purchase an aggregate of 152,867 shares of common stock to six new employees and a grant of 10,714 Restricte...
Page:
1
... NextLast
= add release to Briefcase